local_hospital

Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych i Administracji

Address
ul. Kartuska 4/6, 80-104 Gdansk, Poland

Cardiovascular Research and Risk Management Center

This medical research center operates under the Independent Public Healthcare Facility of the Ministry of Internal Affairs and Administration, specializing in advanced cardiovascular disease research and prevention. The facility focuses on innovative approaches to managing residual cardiovascular risk in high-risk patient populations, particularly those who have experienced acute cardiac events.

  • Biomarker-driven cardiovascular risk stratification and management
  • Post-myocardial infarction care and secondary prevention strategies
  • Intensified cardiovascular risk factor intervention studies

The center is actively engaged in the BIO-RISK-EVENT Study, a randomized controlled trial evaluating intensified residual risk management compared to standard guideline treatment in patients with acute myocardial infarction. This research aims to identify optimal strategies for preventing recurrent cardiovascular events through biomarker-guided therapeutic approaches, representing a significant contribution to personalized cardiovascular medicine and improved patient outcomes in high-risk populations.

Site Overview

assignment
1
connected trial
corporate_fare
1
sponsor
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
1
Total trials linked
Low Activity
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
1
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 1 624 other sites in Poland

description
Trial volume
1
Outperforms 1% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
1sponsors
Outperforms 1% of sites

Therapeutic Area Benchmark — Poland

Select a therapeutic area to compare against other sites in Poland.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Poland

Market Share

Country: Poland

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych i Administracji

Trial Sponsor Phase Status Start Date End Date
Evaluation of Biomarker-Driven Intensification of Cardiovascular Risk Management in Patients with High Risk for Recurrent Events Using Icosapent Ethyl and Drug CombinationMedical University Of GrazPhase IIIRecruitingJun 2025

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Colchicine1Unknown2025-06-122025-06-12

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.